Gene · 8739
NIH grants1,203
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,203
Download this page as JSON| Grant | Title | HRK papers | Newest fiscal year |
|---|---|---|---|
| P50CA211015 | UCLA SPORE in Brain Cancer | 1 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 1 | 2025 |
| R00CA252602 | Targeting mitochondrial dynamics in drug-resistant acute myeloid leukemia | 1 | 2025 |
| R01AG032289 | Biological predictors of brain aging trajectories | 1 | 2025 |
| R01AI080607 | Studies in Poxvirus Host Range Genes and Tropism | 1 | 2025 |
| R01AI153708 | B cell memory in human food allergy | 1 | 2025 |
| R01AR043369 | MITF from control of pigmentation to melanoma risk | 1 | 2025 |
| R01CA121118 | A High-Throughput Model for Human Melanoma | 1 | 2025 |
| R01CA126792 | Autophagy and Pro-metastatic Differentiation | 1 | 2025 |
| R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 1 | 2025 |
| R01CA197999 | Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers | 1 | 2025 |
| R01CA200310 | BNIP3 and BNIP3L (NIX) in lipid homeostasis and growth control in the liver | 1 | 2025 |
| R01CA214608 | The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase | 1 | 2025 |
| R01CA222349 | Non-canonical Caspase-8 Activation on Autophagosomal Membranes | 1 | 2025 |
| R01CA238039 | Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway | 1 | 2025 |
| R01CA249062 | Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells | 1 | 2025 |
| R01CA262758 | Mechanisms of venetoclax combination activity in acute myeloid leukemia | 1 | 2025 |
| R01CA263593 | Mechanism-based targeting of unique survival signaling in residual tumors | 1 | 2025 |
| R01CA266298 | Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia | 1 | 2025 |
| R01CA266389 | Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/grants?page=6